US EPA Authorises Grafysorber for Use in US

RNS Number : 0589H
Directa Plus PLC
04 April 2022
 

4 April 2022

 

Directa Plus plc

("Directa Plus" or the "Company")

 

US EPA Authorises Grafysorber for Use in the United States

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, announces that it has received authorisation from the United States Environment Protection Agency for the Company's Grafysorber® technology to be used on any oil contamination on US territory. 

 

Directa Plus's patented Grafysorber® technology is a graphene-based solution for treating water sludges and emulsions containing hydrocarbons and is at least five times more effective than current technologies - adsorbing more than 100 times its own weight of oil-based pollutants. In addition, Grafysorber® is sustainably produced, non-flammable and reusable, with the adsorbed hydrocarbons recoverable.

 

The approval follows a first presentation of the technology to the California Natural Resource Agency, the highest Californian environmental authority, which suggested that Directa Plus undertook the authorization process with the US Federal Environmental Protection Agency (EPA) to allow the use of Grafysorber® in the United States.  After a full review of the information provided by Directa Plus, the US EPA has issued an official authorization letter stating that Grafysorber® fully meets the EPA's legal requirements and can be used at any oil spill on US territory.

 

Commenting, Giulio Cesareo, Founder and CEO of Directa Plus, said: "The EPA approval is the vital first step towards entering the very large US oil decontamination market.  We believe that the benefits of using Grafysorber® compared with competing products will generate significant interest from the US decontamination companies we can now start approaching.  We have always expected that this patented technology would have considerable export potential and this authorization allows us to begin to realise that potential. In addition, we expect to shortly be able to announce the first order of Grafysorber® from a UK company."

 

For further information please visit http://www.directa-plus.com/ or contact:

 

Directa Plus plc

+39 02 36714458

Giulio Cesareo, CEO / Giorgio Bonfanti, CFO

 

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

+44 131 220 6939

Neil McDonald / Adam Rae

 

 

 

Singer Capital Markets (Joint Broker)

+44 20 7496 3069

Rick Thompson / Phil Davies

 

 

 

Tavistock (Financial PR and IR)

+44 20 7920 3150

Simon Hudson / Heather Armstrong

 

 

About Directa Plus

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to its properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. The Company holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

-ends-

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEAXLDEEAAEFA
UK 100

Latest directors dealings